Drugs

List of Determinations Including Written Request

Pediatric Exclusivity Determinations Made under Section 505A of the Federal Food, Drug, and Cosmetic Act (the Act), as amended by the FDA Amendments Act of 2007 (FDAAA)

In accordance with section 505A(e)(1) of the Act, as amended by FDAAA (Pub. L. No. 110-85), the following list identifies those approved drugs for which a pediatric exclusivity determination was made, on or after September 27, 2007.  In addition, it provides a link to a copy of the Written Request and any amendments.

NOTE: Only applications held by the identified sponsor were granted pediatric exclusivity. We will update this page each time a determination is made.

The administrative amendments issued during the summer of 2002 and spring of 2004, which cover the passage of the Best Pharmaceuticals for Children Act on January 4, 2002, and the requirement for submitted reports to include more specific information on racial and ethnic minorities, respectively, may not be listed below for original Written Requests that predate their release (e.g., bicalutamide).

N=99

DrugSponsorDetermination DateWritten Request and Related Documents
Abatacept  BMS2/14/2017
 
AcetaminophenMallinckrodt7/11/2016
AlbuterolGlaxoSmithKline8/27/2008
AlfuzosinSanofi Aventis9/7/2010
AliskirenNoden Pharma DAC10/3/2017
AlmotriptanJohnson & Johnson Pharmaceutical Research & Development1/13/2009
AnastrozoleAstraZeneca11/14/2007
AripiprazoleOtsuka11/14/2007
AsenapineForest Labs3/3/2015
Atazanavir BMS6/23/2015
Azelastine/Fluticasone and AzelastineMeda Pharmaceuticals3/23/2015
BendamustineCephalon5/24/2012
BicalutamideAstraZeneca9/19/2008
BivalirudinThe Medicines Company6/17/2009
BortezomibMillennium Pharmaceuticals8/14/2015
Budesonide/FormoterolAstraZeneca
 
1/25/2017
 
CabazitaxelSanofi Aventis
 
5/18/2017
CandesartanAstraZeneca Pharmaceuticals LP7/20/2009
CapecitabineHoffman-La Roche, Inc.8/28/2013
CaspofunginMerck & Co., Inc.4/15/2008
CetirizineNicox Ophthalmics 8/29/16  
ClopidogrelSanofi Aventis1/20/2011
ColesevelamDaiichi Sankyo Pharma2/17/2009
CysteamineHorizon12/12/2017
DarunavirTibotec6/7/2011
DasatinibBMS9/27/2018
DexmedetomidineHospira3/12/2013
DifluprednateAlcon3/21/2013
DocetaxelSanofi Aventis3/17/2010
DuloxetineEli Lilly7/2/2012
EfavirenzBMS1/29/2013
Eltrombopag Novartis8/14/2015
EntecavirBMS12/5/2013
EplerenonePfizer10/24/2007
ErlotinibOSI Pharmaceuticals3/18/2015
EsomeprazoleAstraZeneca LP5/1/2009
EszopicloneSunovion6/29/2012
Etravirine Janssen6/21/2018
EverolimusNovartis7/10/2012
EzetimibeSchering Corporation2/14/2008
FamciclovirNovartis9/21/2009
FinafloxacinAlcon8/25/2014

Fingolimod  

 

Novartis4/16/2018
 
FosamprenavirViiV Healthcare1/10/2012
FosaprepitantMerck 3/23/2018
FulvestrantAstraZeneca2/1/2011
GatifloxacinAllergan5/19/2009
GuanfacineShire10/17/2014
IpilimumabBMS7/20/17
Ixabepilone BMS4/5/2011
LansoprazoleTap Pharmaceutical Products, Inc.7/15/2008
LevetiracetamUCB, Inc.6/3/2008
LevocetirizineUCB, Inc.8/25/2009
Loteprednol/TobramycinBausch & Lomb12/28/2010
Lopinavir/RitonavirAbbott Laboratories3/7/2008
LurasidoneSunovion12/20/2016
MemantineForest Labs6/16/2014
Nilotinib  Novartis3/20/2018
Nitric OxideINO Therapeutics11/2/2010
OlmesartanDaiichi Sankyo10/7/2009
OlopatadineAlcon Research, Ltd.8/12/2009
OlopatadineAlcon Research, Ltd.12/16/2014
PaliperidoneOrtho-McNeil-Janssen Pharmaceuticals, Inc.1/5/2011
PalonosetronHelsinn4/10/2014
PantoprazoleWyeth Pharmaceuticals, Inc.2/17/2009
PemetrexedEli Lilly12/3/2010
Phenylephrine/KetorolacOmeros12/6/2017
Prasugrel  Eli Lilly5/23/16
QuetiapineAstraZeneca Pharmaceuticals LP1/23/2009
RabeprazoleEisai12/4/2012
RaltegravirMerck8/14/2017
RisedronateProcter & Gamble Pharmaceuticals, Inc.4/24/2009
RizatriptanMerck9/20/2011
RocuroniumOrganon, Inc.4/3/2008
RosuvastatinAstraZeneca Pharmaceuticals LP7/7/2009
RufinamideEisai1/13/2015
SapropterinBioMarin3/13/2014
SaquinavirHoffman-La Roche, Inc.10/26/2010
SildenafilPfizer2/9/2012
SolifenacinAstellas7/20/2017
Sumatriptan/NaproxenGlaxoSmithKline/Pernix4/16/2015
Tadalafil   Eli Lilly 11/16/2017 
TamsulosinBoehringer Ingelheim9/17/2009
Tavaborole NEWAnacor7/18/2018
Tbo-filgrastim NEWSicor
 
7/18/2018
Technetium Tc99 sestamibiBMS1/11/2008
TemsirolimusPfizer2/28/2012
TenofovirGilead Sciences, Inc.9/6/2011
TiotropiumBoehringer Ingelheim Pharmaceuticals, Inc.12/14/16
TipranavirBoehringer Ingelheim Pharmaceuticals, Inc.3/7/2008
Tocilizumab NEWGenentech/Hoffmann-La Roche
 
7/18/2018
TopiramateOrtho-McNeil-Janssen Pharmaceuticals, Inc.7/24/2008
TrabectedinJanssen6/12/2018
ValacyclovirGlaxoSmithKline2/28/2008
ValganciclovirHoffman-La Roche Inc.7/24/2008
ValproateAbbott12/14/2007
VigabatrinLundbeck10/3/2013
Zoledronic acidNovartis12/21/2007

* Persons with disabilities having problems accessing the PDF files may call (301) 796-3634 for assistance.

Page Last Updated: 10/10/2018
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English